Hindustan Foods
add_icon

Hindustan Foods

508.65
-5.40
(-1.05%)
Market Cap
6,077.44 Cr
PE Ratio
45.71
Volume
80,069.00
Day High - Low
515.05 - 497.05
52W High-Low
608.00 - 421.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
6,077.44 Cr
EPS
9.51
PE Ratio
45.71
PB Ratio
5.88
Book Value
87.08
EBITDA
307.70
Dividend Yield
0.00 %
Industry
FMCG
Return on Equity
12.30
Debt to Equity
1.05
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
Hindustan Foods Limited receives demand order worth ₹4.95 crore from Tamil Nadu Commercial Taxes Department for FY 2019-20 related to alleged excess refund released.
positive
Hindustan Foods Limited signed a Business Transfer Agreement to acquire Ultra Beauty Care's manufacturing facility in Aurangabad for INR 19.90 crores, expanding into contract manufacturing of ayurvedic and cosmetic products.
neutral
Hindustan Foods Limited has scheduled an analyst and institutional investor meeting for March 20, 2026, at 11:00 am via virtual mode in Mumbai, featuring Kotak PCG group meeting.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,074.40
#1 4,87,399.21
34.52
64,138.00
2.28
10,671
#1 120.91
34.35
294.70
3,69,222.69
#1 10.48
#1 77,853.00
10.23
#1 20,037
0.11
35.46
508.65
#3 6,077.44
#3 45.71
#3 3,578.90
#1 29.58
#3 110
#3 25.78
59.42
302.65
1,548.84
70.91
1,886.90
10.92
-23
43.10
53.17
3.87
553.41
65.83
216.80
-2.78
11
-61.76
44.56

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
29.58 %
Net Income Growth
17.85 %
Cash Flow Change
31.12 %
ROE
-14.58 %
ROCE
0.07 %
EBITDA Margin (Avg.)
3.74 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
44
53
123
149
145
173
207
248
202
319
384
492
458
472
528
583
599
664
680
661
620
677
730
735
871
886
886
936
998
1,043
1,000
Expenses
40
48
113
142
133
160
193
231
188
298
363
462
432
443
498
551
560
620
635
611
569
621
672
670
795
813
807
856
915
953
911
EBITDA
4
5
10
7
11
13
15
18
15
22
22
30
26
29
30
31
39
44
45
50
51
56
58
64
76
73
79
80
84
90
89
Operating Profit %
10 %
9 %
8 %
5 %
8 %
7 %
7 %
7 %
7 %
7 %
5 %
6 %
6 %
6 %
6 %
5 %
6 %
6 %
6 %
7 %
8 %
8 %
8 %
8 %
8 %
8 %
8 %
8 %
8 %
8 %
9 %
Depreciation
1
1
2
2
2
3
3
4
4
4
4
5
5
6
6
7
9
10
10
9
11
12
14
18
20
20
20
20
21
22
23
Interest
1
1
2
2
2
3
2
4
4
5
5
5
5
5
5
5
7
9
10
10
11
13
15
18
20
21
20
20
21
20
19
Profit Before Tax
3
4
7
2
7
8
10
10
6
12
12
20
16
18
19
20
23
25
25
31
30
31
29
28
36
32
39
41
42
47
47
Tax
1
1
2
1
2
3
4
3
2
4
1
7
6
7
7
8
8
6
8
11
6
7
7
5
9
9
11
10
10
12
11
Net Profit
2
3
4
2
4
5
6
7
4
8
12
13
10
11
12
12
15
19
17
20
23
25
22
23
27
23
29
31
32
35
36
EPS in ₹
1.77
1.93
2.31
1.00
2.36
2.58
3.16
3.38
1.83
3.74
5.57
5.09
4.79
5.17
5.59
5.43
6.61
1.68
1.51
1.79
2.07
2.19
1.95
2.01
2.38
2.00
2.44
2.62
2.69
2.95
3.02

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
266
539
694
984
1,335
1,925
2,491
Fixed Assets
133
250
271
427
554
908
1,012
Current Assets
119
253
345
440
598
868
1,265
Capital Work in Progress
0
26
54
87
125
9
120
Investments
0
2
0
0
0
0
0
Other Assets
133
261
370
470
656
1,008
1,359
Total Equity & Liabilities
266
539
694
984
1,335
1,925
2,491
Current Liabilities
126
198
266
374
505
689
873
Non Current Liabilities
76
154
207
306
455
590
727
Total Equity
65
187
222
304
375
646
891
Reserve & Surplus
46
165
200
281
352
547
828
Share Capital
14
21
21
23
23
23
24

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-2
24
16
-12
7
3
34
Investing Activities
-40
-145
-92
-139
-220
-381
-289
Operating Activities
-5
17
74
36
99
87
114
Financing Activities
43
153
34
91
128
298
209

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Apr 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
62.62 %
62.62 %
62.62 %
62.62 %
64.85 %
64.85 %
64.85 %
64.85 %
64.85 %
64.85 %
64.85 %
64.85 %
63.81 %
63.81 %
63.81 %
62.22 %
62.22 %
62.22 %
61.31 %
61.31 %
61.31 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.58 %
0.00 %
6.70 %
3.02 %
3.39 %
5.45 %
5.25 %
0.00 %
5.83 %
5.79 %
5.75 %
DIIs
0.12 %
0.03 %
0.06 %
0.03 %
0.03 %
0.03 %
6.55 %
6.55 %
6.65 %
6.58 %
6.04 %
0.06 %
7.19 %
13.44 %
13.80 %
14.07 %
14.56 %
10.51 %
14.25 %
14.41 %
14.60 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.06 %
10.59 %
10.73 %
10.76 %
9.98 %
10.17 %
10.06 %
9.73 %
9.79 %
10.33 %
13.65 %
13.96 %
13.86 %
13.95 %
13.49 %
12.86 %
12.61 %
12.61 %
12.51 %
12.48 %
12.30 %
Others
27.19 %
26.75 %
26.59 %
26.59 %
25.14 %
24.95 %
18.54 %
18.87 %
18.71 %
18.24 %
8.89 %
21.13 %
8.44 %
5.79 %
5.50 %
5.41 %
5.36 %
14.65 %
6.09 %
6.01 %
6.04 %
No of Share Holders
25,295
35,036
38,048
38,446
37,078
38,459
50,576
53,711
60,489
69,988
80,587
86,147
85,364
84,136
79,846
76,794
73,822
73,822
72,312
70,011
66,618

Announcements

Announcement Under Regulation 30 (LODR) - Updates (Intimation Of Order Received Under Section 74 Of CGST/SGST Act 2017)3 days ago
Closure of Trading Window3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
Announcement under Regulation 30 (LODR)-Acquisition6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement Under Regulation 30 (LODR) - Receipt Of Final Order Issued By HonBle National Company Law Tribunal Mumbai Bench In Respect Of Scheme Of ArrangementFeb 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 10, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2026
Results - Financial Results For Dec 31 2025.Feb 10, 2026
Board Meeting Outcome for Board Meeting Outcome For Approval Of An Un-Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Board Meeting Intimation for Un-Audited Consolidated & Standalone Financial Results For Quarter And Nine Months Ended December 31 2025 And Other Businesses Of The Agenda.Feb 04, 2026
Intimation On Conversion Of Statutory AuditorS Firm Into An LLP - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 26, 2025
Announcement Under Regulation 30 (LODR)- Updates (Intimation Of Order Received Under Section 73 Of CGST/SGST Act 2017)Dec 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Results - Financial Results For Sep 30 2025.Nov 12, 2025
Board Meeting Outcome for Approval Of An Un-Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Board Meeting Intimation for Approval For Un-Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half-Yearly Ended September 302025.Nov 06, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingOct 16, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 15, 2025
Board Meeting Outcome for Outcome Of Board MeetingOct 15, 2025
Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Announcement Under Regulation 30 (LODR) - ESG RatingsOct 07, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Announcement Under Regulation 30 (LODR)- Chairmans SpeechSep 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesSep 10, 2025
Equity Shareholders Meeting -NCLT Convened Meeting On Oct 15 2025Sep 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025

Mutual Fund Holdings

Technical Indicators

RSI(14)
Neutral
59.42
ATR(14)
Volatile
17.56
STOCH(9,6)
Neutral
68.73
STOCH RSI(14)
Overbought
96.16
MACD(12,26)
Bullish
4.13
ADX(14)
Weak Trend
17.69
UO(9)
Bearish
63.45
ROC(12)
Uptrend And Accelerating
6.11
WillR(14)
Overbought
-13.89